Exploiting new strategies in combating head and neck carcinoma: A comprehensive review on phytochemical approaches passing through PI3K/Akt/mTOR signaling pathway

Fuente: Wiley Open Access
Enregistré dans:
Détails bibliographiques
Auteurs principaux: Amin Iranpanah, Mohammad Bagher Majnooni, Hossein Biganeh, Roshanak Amirian, Mohsen Rastegari‐Pouyani, Rosanna Filosa, Wai San Cheang, Sajad Fakhri, Haroon Khan
Format: Artículo Open Access
Publié: Wiley 2024
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1867004269079560192
author Amin Iranpanah
Mohammad Bagher Majnooni
Hossein Biganeh
Roshanak Amirian
Mohsen Rastegari‐Pouyani
Rosanna Filosa
Wai San Cheang
Sajad Fakhri
Haroon Khan
author_facet Amin Iranpanah
Mohammad Bagher Majnooni
Hossein Biganeh
Roshanak Amirian
Mohsen Rastegari‐Pouyani
Rosanna Filosa
Wai San Cheang
Sajad Fakhri
Haroon Khan
Amin Iranpanah
Mohammad Bagher Majnooni
Hossein Biganeh
Roshanak Amirian
Mohsen Rastegari‐Pouyani
Rosanna Filosa
Wai San Cheang
Sajad Fakhri
Haroon Khan
collection Wiley Open Access
contents Exploiting new strategies in combating head and neck carcinoma: A comprehensive review on phytochemical approaches passing through PI3K/Akt/mTOR signaling pathway Amin Iranpanah Mohammad Bagher Majnooni Hossein Biganeh Roshanak Amirian Mohsen Rastegari‐Pouyani Rosanna Filosa Wai San Cheang Sajad Fakhri Haroon Khan Phytotherapy Research AbstractRecently, malignant neoplasms have growingly caused human morbidity and mortality. Head and neck cancer (HNC) constitutes a substantial group of malignancies occurring in various anatomical regions of the head and neck, including lips, mouth, throat, larynx, nose, sinuses, oropharynx, hypopharynx, nasopharynx, and salivary glands. The present study addresses the phosphoinositide 3‐kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway as a possible therapeutic target in cancer therapy. Finding new multitargeting agents capable of modulating PI3K/Akt/mTOR and cross‐linked mediators could be viewed as an effective strategy in combating HNC. Recent studies have introduced phytochemicals as multitargeting agents and rich sources for finding and developing new therapeutic agents. Phytochemicals have exhibited immense anticancer effects, including targeting different stages of HNC through the modulation of several signaling pathways. Moreover, phenolic/polyphenolic compounds, alkaloids, terpenes/terpenoids, and other secondary metabolites have demonstrated promising anticancer activities because of their diverse pharmacological and biological properties like antiproliferative, antineoplastic, antioxidant, and anti‐inflammatory activities. The current review is mainly focused on new therapeutic strategies for HNC passing through the PI3K/Akt/mTOR pathway as new strategies in combating HNC. 10.1002/ptr.8228 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/ptr.8228
format Artículo Open Access
id wiley_oa_10_1002_ptr_8228
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Exploiting new strategies in combating head and neck carcinoma: A comprehensive review on phytochemical approaches passing through PI3K/Akt/mTOR signaling pathway
Amin Iranpanah
Mohammad Bagher Majnooni
Hossein Biganeh
Roshanak Amirian
Mohsen Rastegari‐Pouyani
Rosanna Filosa
Wai San Cheang
Sajad Fakhri
Haroon Khan
Phytotherapy Research
Exploiting new strategies in combating head and neck carcinoma: A comprehensive review on phytochemical approaches passing through PI3K/Akt/mTOR signaling pathway Amin Iranpanah Mohammad Bagher Majnooni Hossein Biganeh Roshanak Amirian Mohsen Rastegari‐Pouyani Rosanna Filosa Wai San Cheang Sajad Fakhri Haroon Khan Phytotherapy Research AbstractRecently, malignant neoplasms have growingly caused human morbidity and mortality. Head and neck cancer (HNC) constitutes a substantial group of malignancies occurring in various anatomical regions of the head and neck, including lips, mouth, throat, larynx, nose, sinuses, oropharynx, hypopharynx, nasopharynx, and salivary glands. The present study addresses the phosphoinositide 3‐kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway as a possible therapeutic target in cancer therapy. Finding new multitargeting agents capable of modulating PI3K/Akt/mTOR and cross‐linked mediators could be viewed as an effective strategy in combating HNC. Recent studies have introduced phytochemicals as multitargeting agents and rich sources for finding and developing new therapeutic agents. Phytochemicals have exhibited immense anticancer effects, including targeting different stages of HNC through the modulation of several signaling pathways. Moreover, phenolic/polyphenolic compounds, alkaloids, terpenes/terpenoids, and other secondary metabolites have demonstrated promising anticancer activities because of their diverse pharmacological and biological properties like antiproliferative, antineoplastic, antioxidant, and anti‐inflammatory activities. The current review is mainly focused on new therapeutic strategies for HNC passing through the PI3K/Akt/mTOR pathway as new strategies in combating HNC. 10.1002/ptr.8228 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Exploiting new strategies in combating head and neck carcinoma: A comprehensive review on phytochemical approaches passing through PI3K/Akt/mTOR signaling pathway
topic Phytotherapy Research
url https://onlinelibrary.wiley.com/doi/10.1002/ptr.8228